Author

Mitra Harrison

National Institutes of HealthPrimary ORCID profile (0009-0003-6976-0120 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Mitra HarrisoniD1 paper · Duke University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alexander C VostaliD· 2 shared Andy A. Patamawenu· 2 shared Anna Hostal· 2 shared Breanna KimiD· 2 shared Ceanna Cooney· 2 shared Ellison Ober· 2 shared Freya van't VeeriD· 2 shared Jeffrey I. CoheniD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Alexander C VostalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transgene Expression Kinetics and Replication Potential of Recombinant Adenovirus Serotype 4 in a Mouse Model and its Use as a Herpes Simplex Virus Vaccine

Alexander C Vostal, Dawid Maciorowski, James M. Readler, Isabella S. Pytel, Andy A. Patamawenu, Ceanna Cooney, Peyton M. Roeder, Rachel Roenicke, Freya van't Veer, Tae Kim, Ellison Ober, Yuyan Yi, Jingwen Gu, Mitra Harrison, Breanna Kim, , Jeffrey I. Cohen

This paper evaluates transgene expression and viral replication of recombinant Ad4 in mice, showing protective efficacy against HSV-2 infection.

bioRxiv · May 17, 2026 · PreprintImmunology

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines

Breanna Kim, Rachel Roenicke, P J Roeder, Isabel Steinberg, Andy A. Patamawenu, Mitra Harrison, Freya van't Veer, Emma Koory, Jane Xie, Tulley Shofner, Kenta Matsuda, Eleanor Wettstein, Ellison Ober, Ceanna Cooney, Tae Sung Kim, , Mark Connors

This study compares intranasal and intramuscular vaccines, finding that the intranasal Ad4-S vaccine provides more durable and effective immune responses against SARS-CoV-2 in preclinical models.

bioRxiv · Feb 5, 2026 · PreprintImmunology